Oncobesity News Posts

The Executive Briefing: Saks in Crisis; The Battle for Lululemon; A Holiday Shopping Miracle
America’s largest department store operator is on the brink, Lululemon’s founder is making moves and GLP-1 pills promise to shake up fashion this year. Read

Thursday briefing: Why skinny jabs’ short-term fix comes with long-term concerns
In today’s newsletter: A new study shows that people don’t just regain weight after stopping GLP-1 drugs, they see other positive health markers reverse –

Brain Stimulation Matches Semaglutide for Weight Loss
In a retrospective study, repetitive transcranial magnetic stimulation produces weight loss comparable to semaglutide 0.5 mg/wk in patients with obesity and type 2 diabetes. Medscape

Thai FDA seeks to tighten controls on GLP-1 ‘slimming pens’, proposing special controlled-drug status
The move will limit sales to pharmacies with a doctor’s prescription amid misuse online.

Exacerbation of sucrose-induced visceral obesity and glucose intolerance by ovariectomy and its GLP-1-dependent amelioration by the rare sugar D-allulose
Estrogen deficiency after menopause promotes visceral fat accumulation and insulin resistance, thereby increasing the risk of type 2 diabetes. Although hormone replacement therapy is partially

People coming off weight-loss injections risk fast weight gain – BBC
People coming off weight-loss injections risk fast weight gain BBC People who stop taking GLP-1 drugs regain weight faster, review finds CBC Less than two years after

People who stop taking GLP-1 drugs regain weight faster, review finds
When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those who stopped a diet or exercise program,

People who stop taking weight-loss jabs regain weight in under two years, study reveals
Analysis finds those who stopped using medication saw weight return four times faster compared with other weight loss plans People who stop taking weight loss

Weight lost on GLP-1 drugs is regained within two years of stopping
The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at

What Nvidia just did could rewire the AI race
Nvidia isn’t going to wait until spring. The AI chipmaker just changed the rules for its competitors and maybe for the whole AI infrastructure timeline,

Lack of support for people on weight loss drugs leaves them vulnerable to nutritional deficiencies, say experts
In research published today in Obesity Reviews, the team, led by Dr Marie Spreckley from the University of Cambridge, found a lack of robust evidence

STAT+: Stopping obesity drugs means people regain weight and lose heart health benefits
The list of health benefits from weight loss drugs is long, but they last only as long as people take them. Beyond being good for

Get Wegovy Pills Online | Wegovy Tablet Online Prescription and Delivery – GoodRx
Get Wegovy Pills Online | Wegovy Tablet Online Prescription and Delivery GoodRx Wegovy is now available as a pill. Here’s what you need to know CNN First

RFK Jr. is pushing Americans to eat more red meat and dairy as Starbucks, Chipotle, and others cash in on protein craze
The Trump administration wants each American’s plate loaded with protein at every meal, and food chains are eating it up. New nutrition guidelines released on

Mindy Kaling shows 40-pound slimdown in daring cutout dress
The actress shared that she limits her portions and works out frequently after being hit with speculation that she used a GLP-1 weight loss drug.

How to get stronger
Illustration by Liz Zonarich/Harvard Staff Health How to get stronger If you’re not failing all the time, you’re doing it wrong, says fitness expert January

New US dietary guidelines elevate meat and full-fat dairy, ignite protein debate: ‘Most Americans already eat plenty’
Nutritionists have welcomed the emphasis on reducing consumption of highly processed foods in the new Dietary Guidelines for Americans, but say their emphasis on animal

The Health Tech Trends to Watch During CES 2026
CES 2026 highlights health tech megatrends including GLP-1 ecosystem growth, AI-powered precision medicine, and remote care through wearable devices.

OpenAI launches ChatGPT Health for personalized wellness insights
OpenAI has introduced ChatGPT Health, a specialized feature within ChatGPT designed for health and wellness inquiries that can be personalized with your own data. Users

The US government says you should be proteinmaxxing. Experts say that can backfire — here’s why.
New U.S. dietary guidelines have beef with the “war on protein.” Igor Jovanovic/Getty Images The latest Dietary Guidelines for Americans emphasize more protein and fewer

KeyBanc Sees Injectable GLP-1s Driving Ongoing Demand for WST
West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 14 Best Dividend Growth Stocks to Buy and Hold in 2026. KeyBanc sees limited risk to

NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States.
Rachel Sachs is a professor of law at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The Wegovy Pill Is Now Available, but There’s 1 Big Catch Patients Need to Know
The studies comparing the GLP-1 pill to injections are promising.

What the new GLP-1 pill means for obesity treatment
Can a GLP-1 Pill Revive Novo Nordisk? | Prof G Markets Check out the full episode, available now: https://www.youtube.com/watch?v=Z70I9ASCU7A

Future diabetes care seen leaning towards GLP-1 drugs
The diabetes treatment landscape in India is on the brink of transformation. Innovative GLP-1 medications are set to redefine therapy standards, providing remarkable advantages in

What is the New Food Pyramid 2026? Dietary Guidelines for Americans launched: key changes
USDA The Trump administration has unveiled the 2025–2030 Dietary Guidelines for Americans, marking a significant shift in national nutrition advice. Spearheaded by Health and Human

Ozempic could lower the risk of one of the fastest-rising cancers in young people
New evidence shows that GLP-1 drugs might be more effective than aspirin at preventing colorectal cancer, while also significantly lowering the risk of death for

This Could Be Key to Pfizer’s Turnaround in 2026
Key Points Pfizer has been making deals in recent years to enhance its long-term growth potential. Last month, it reached a GLP-1 licensing deal with

A former restaurant critic changed his eating habits. You can, too.
By Pete Wells, The New York Times Amazon lists more than 70,000 diet books. Not a single one is called “Eat Like a Restaurant Critic.”

Heuro Health chooses Milliman CareFlowIQ’s real-time clinical intelligence to advance obesity care
SEATTLE–(BUSINESS WIRE)–Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, today announced a new client relationship with Heuro Health, a

Real-world answers for patients running out of time
Health Real-world answers for patients up against the clock Jacob Sweet Harvard Staff Writer January 7, 2026 5 min read Insurance data can help fill

Dunkin’, Starbucks and more serve up protein-packed menu items amid the rise of GLP-1 drugs
Protein is officially having its moment at restaurants nationwide. Dunkin’ is the latest chain to add protein to its menu, following others like Starbucks, Subway

Ochsner launches program to cut GLP-1 costs
Ochsner Connected Health, part of New Orleans-based Ochsner Health, has partnered with Crux to expand access to affordable obesity care through a new employer benefits

Throne, from the co-founder of Whoop, uses computer vision to study your poop
Throne has rocked up to CES 2026 to show off its forthcoming toilet computer which uses computer vision to study your poop. It hangs from

9 food trends that will be everywhere in 2026
Food trends for 2026 include sweet-and-spicy flavors, bite-sized menu items, cabbage, and fast-casual Indian cuisine. Nungning20/Shutterstock Food trends for 2026 include sweet-and-spicy flavors, as well

Destination XL (DXLG) Q3 2025 Earnings Transcript
Image source: The Motley Fool. DATE Thursday, December 4, 2025 at 9 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Harvey Kanter Incoming Chief Executive

Albertsons (ACI) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, January 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Interim Chief Executive Officer — Susan Morris President and

Cal-Maine Foods (CALM) Q2 2026 Earnings Transcript
Image source: The Motley Fool. DATE Wednesday, January 7, 2026 at 9 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Sherman Miller Vice

The Builder’s Notes: Your Patient Data Is Being Sold.
The Builder’s Notes: Your Patient Data Is Being Sold. You Don’t Know, Don’t Consent, and Get Nothing. Hospitals sell your medical records to AI companies, pharmaceutical

Ochsner Connected Health and Crux launch partnership to make obesity management medicine accessible and affordable for employers nationwide
Employers gain access to comprehensive cardiometabolic care and cost-effective GLP-1 for obesity management coverage NEW ORLEANS, Jan. 7, 2026 /PRNewswire/ — Ochsner Connected Health announced